1. Home
  2. PATK vs BEAM Comparison

PATK vs BEAM Comparison

Compare PATK & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patrick Industries Inc.

PATK

Patrick Industries Inc.

HOLD

Current Price

$90.66

Market Cap

3.0B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$28.96

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PATK
BEAM
Founded
1959
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.0B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
PATK
BEAM
Price
$90.66
$28.96
Analyst Decision
Buy
Buy
Analyst Count
8
12
Target Price
$122.75
$50.75
AVG Volume (30 Days)
430.3K
1.8M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
2.02%
N/A
EPS Growth
N/A
82.31
EPS
1.10
N/A
Revenue
$29,000,000.00
$24,000.00
Revenue This Year
$5.78
N/A
Revenue Next Year
$6.51
$33.77
P/E Ratio
$82.02
N/A
Revenue Growth
262.50
33.33
52 Week Low
$83.96
$15.60
52 Week High
$148.50
$36.44

Technical Indicators

Market Signals
Indicator
PATK
BEAM
Relative Strength Index (RSI) 40.60 47.74
Support Level $87.53 $28.50
Resistance Level $98.39 $32.01
Average True Range (ATR) 2.73 1.80
MACD 0.54 0.10
Stochastic Oscillator 27.39 41.76

Price Performance

Historical Comparison
PATK
BEAM

About PATK Patrick Industries Inc.

Patrick Industries Inc is a component solutions provider for the recreational vehicle (RV), marine, powersports, manufactured housing (MH), and various industrial markets, including single and multi-family housing, hospitality, institutional, and commercial markets. The company operates within two reportable segments, Manufacturing and Distribution. The majority of its revenue is generated from the Manufacturing segment, which offers laminated products utilized to produce furniture, shelving, walls, and countertops; fabricated aluminum products; cabinet products, doors, components, and custom cabinetry; interior passage doors and baggage doors; RV and marine furniture, etc. Geographically, the company mainly operates in the United States, with a small presence in Mexico, China, and Canada.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: